Adrenergic beta-antagonist/Related Articles: Difference between revisions
Jump to navigation
Jump to search
imported>Gareth Leng |
imported>Gareth Leng No edit summary |
||
Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
==Parent topics== | ==Parent topics== | ||
{{r|Adrenergic receptor}} | |||
{{r|Adrenergic agent}} | |||
{{r| | |||
{{r| | |||
==Other related topics== | ==Other related topics== | ||
{{r|Adrenergic beta-agonist}} | {{r|Adrenergic beta-agonist}} | ||
{{r|Adrenergic uptake inhibitor}} | {{r|Adrenergic uptake inhibitor}} |
Revision as of 06:58, 17 October 2010
- See also changes related to Adrenergic beta-antagonist, or pages that link to Adrenergic beta-antagonist or to this page or whose text contains "Adrenergic beta-antagonist".
Parent topics
- Adrenergic receptor [r]: Cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. The two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. [e]
- Adrenergic agent [r]: Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. [e]
- Adrenergic beta-agonist [r]: Class of drugs used to treat asthma and other pulmonary disease states. [e]
- Adrenergic uptake inhibitor [r]: Drug which acts as a reuptake inhibitor for the neurotransmitters norepinephrine and epinephrine by blocking the action of the norepinephrine transporter. [e]